Physitrack PLC (STO:PTRK)
7.70
0.00 (0.00%)
Jul 17, 2026, 3:44 PM CET
Physitrack Revenue
Physitrack had revenue of 3.24M EUR in the quarter ending March 31, 2026, with 3.26% growth. This brings the company's revenue in the last twelve months to 13.62M, up 2.20% year-over-year. In the year 2025, Physitrack had annual revenue of 13.52M, down -2.50%.
Revenue (ttm)
13.62M EUR
Revenue Growth
+2.20%
P/S Ratio
0.84
Revenue / Employee
378.38K EUR
Employees
36
Market Cap
125.21M SEK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.52M | -346.68K | -2.50% |
| Dec 31, 2024 | 13.87M | -880.28K | -5.97% |
| Dec 31, 2023 | 14.75M | 2.24M | 17.87% |
| Dec 31, 2022 | 12.51M | 4.70M | 60.10% |
| Dec 31, 2021 | 7.81M | 4.76M | 155.86% |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.24B |
| Swedish Orphan Biovitrum AB | 28.96B |
| Sectra AB | 3.65B |
| Camurus AB | 2.27B |
| Arcoma AB | 127.06M |
| Nosa Plugs AB | 27.87M |
| Biovica International AB | 13.49M |
| NextCell Pharma AB | 9.24M |
Physitrack News
- 3 months ago - Physitrack Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Physitrack Quarterly report: Q1 2026 - Filings
- 3 months ago - Physitrack Slides: Q1 2026 - Filings
- 5 months ago - Physitrack Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Physitrack Annual report: Q4 2025 - Filings
- 5 months ago - Physitrack Quarterly report: Q4 2025 - Filings
- 5 months ago - Physitrack Slides: Q4 2025 - Filings
- 9 months ago - Physitrack Earnings Call Transcript: Q3 2025 - Transcripts